Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 15 of 15 for “"Factor XIIa"”.
-
Cloning, characterization, and analysis of the complete bovine factor XIIa inhibitor cDNA
… human Cl esterase inhibitor is called the bovine factor Xlla inhibitor. Like the human Cl esterase inhibitor, bovine factor Xlla inhibitor is a serine protease inhibitor with a reported molecular weight of between 72,000 and 92,000 Da. To determine the primary structure of bovine factor Xlla …
-
Identification of the complementary binding domains of histidine-rich glycoprotein and factor XIIa responsible for contact pathway inhibition
Recent studies suggest that factor (F) XII, which is dispensable for hemostasis, is important for thrombus stabilization and growth. Therefore, FXIIa inhibition may attenuate thrombosis without disrupting hemostasis. FXII activation is stimulated by polyanions such as polyphosphates released from …
-
Identification, characterization, and optimization of fragment hits against coagulation factor XIIa supported by affinity capillary electrophoresis and biochemical assay
Coagulation factor XIIa (FXIIa) emerges as a promising target for thromboses induced by blood-contacting devices and several inflammatory diseases, such as hereditary angioedema, Alzheimer’s disease, and multiple sclerosis. FXIIa plays a key role in the initial events that trigger medical …
-
Blood-surface Interaction: Improving the Assessment of Blood Compatible Biomaterials to Mitigate the Intrinsic Pathway Activation
… conditions. Through comprehensive assessment of Factor XII adsorption/activation, thrombin generation, and fibrin clot formation, we demonstrate that zwitterionic poly(carboxybetaine) copolymer surfaces exhibit superior blood compatibility, while plasma-polymerized hexafluoropropylene (ppC₃F₆) …
-
SURFACE MODIFICATION WITH POLYETHYLENE GLYCOL-PROTEIN CONJUGATES FOR IMPROVED BLOOD COMPATIBILITY
… (CTI), a specific inhibitor of clotting factor XIIa. Gold, used as a model substrate, was modified with PEG and anticoagulant molecules using two methods referred to as sequential and direct. In the sequential method PEG was first immobilized on the surface and then the bioactive molecule …
-
The tissue factor-factor VII(a) complex in blood coagulation
… cascade in vivo is mediated by tissue factor (TF), which functions as the cell surface receptor and catalytic cofactor for factor VIIa (FVIIa), as well as the mediator for the autoactivation of factor VII (FVII) to FVIIa. Upon vascular injury, TF is exposed to the bloodstream where it …
-
The Role of Thrombin Exosites 1 and 2 in the Activation of Factor XI by Thrombin
Factor XI (FXI) is the zymogen of the coagulation protease factor XIa (FXIa) that contributes to thrombin generation through the intrinsic pathway. FXI is activated by the contact pathway protease, factor XIIa (FXIIa), in a high molecular weight kininogen-dependent manner. It is also known to be …
-
AN IN VITRO MODEL TO EVALUATE THE EFFECTS OF ANTICOAGULANTS ON CLOT FORMATION IN THE PRESENCE OF LOW PLATELET COUNTS
… Clotting was activated with tissue factor (TF) and calcium, in the presence of factor XIIa inhibitor, corn trypsin inhibitor. One of the following anticoagulants at therapeutic concentration was added to the mixture: unfractionated heparin (UFH), dalteparin, fondaparinux, rivaroxaban …
-
Blood response to biomaterials : in vitro and clinical investigation of the contact phase of blood coagulation
… contact activation, based on measurement of factor XII activity, were investigated. A factor Xll-like activity (FXIIA) was measured by a modified chromogenic substrate assay. FXIIA was determined in vitro in the plasma supernatant and on the membrane surface following blood-membrane contact. …
-
Establishing The Transient Mass Balance Of Thrombosis Under Venous Flow: From A Microfluidic Approach To A Reduced Model
… flow. Using microfluidic perfusion of Factor XIIa-inhibited human whole blood over a 250-micron long patch of collagen/tissue factor and immunoassays of the effluent for fragment 1.2, thrombin-antithrombin, and D-dimer (post-endpoint plasmin digest), we sought to establish the transient …
-
Structure-function study of a plant protein proteinase inhibitor: site-directed mutagenesis of Cucurbita maxima trypsin inhibitor V
… pumpkin, is an inhibitor of trypsin and [beta]-Factor XIIa (FXIIa). CMTI-V binds to enzyme as would a substrate, but whereas substrate is cleaved at its scissile bond and the resulting fragments released, CMTI-V remains bound to its target enzyme, thus inhibiting activity. Amino acids at the …
-
Faktor XIIa induziert als Ligand des thrombozytären Komplementrezeptors gC1qR eine direkte Thrombozytenaktivierung und -aggregation sowie die Bildung von Mikropartikeln
… Untersuchungen zeigen, dass aktivierter Faktor XIIa (FXIIa) während der Entstehung arterieller Thromben eine entscheidende Rolle spielt, wobei er hingegen bei der physiologischen Hämostase nur von untergeordneter Bedeutung zu sein scheint. Die Hemmung der Thrombozytenfunktion stellt ein …
-
Interactions between the kallikrein-kinin system, the complement system and extracellular vesicles in vascular inflammation
… II the effect of KKS activation, by kaolin or factor XIIa, was studied directly on ADP-preactivated glomerular endothelial cells showing that complement factors C3a, Ba, C5b-9 were released from or deposited on cell lysates. These effects were inhibited by a B1 receptor antagonist. The B1 …
-
LOCALIZATION OF LIGAND-BINDING EXOSITES IN THE CATALYTIC DOMAIN OF FXIa AND DETERMINATION OF THE ROLES OF CALCIUM AND THE HEAVY CHAIN OF FXIa IN FIX ACTIVATION BY FXIa
Coagulation factor XI (FXI) is a plasma zymogen that is activated to FXIa, the catalytic domain of which contains exosites that interact with its normal macromolecular substrate (FIX), and its major regulatory inhibitor (protease nexin-2 kunitz protease inhibitor, PN2KPI). To localize the catalytic …